Medical Devices & Sensors
Implantables, point-of-care diagnostics and biosensors.
The medical device frontier is increasingly defined by miniaturized, AI-enabled, and continuously sensing platforms. GSBG 2027 will examine brain-computer interfaces from Neuralink (N1 implant clinical experience), Synchron (Stentrode), and Paradromics, alongside Precision Neuroscience's thin-film cortical arrays. The track will cover continuous glucose monitoring evolution (Dexcom G7, Abbott Libre 3) and its expansion into non-diabetic populations, multi-analyte wearables for stress and metabolic monitoring, ingestible diagnostics, and CRISPR-based point-of-care platforms (SHERLOCK, DETECTR). Implantable bioelectronic medicine — vagus nerve stimulation, closed-loop neuromodulation — will round out the program.
- Brain-computer interfaces: Neuralink N1, Synchron Stentrode, Paradromics
- Continuous glucose monitoring and multi-analyte wearable biosensors
- CRISPR-based diagnostics: SHERLOCK, DETECTR for point-of-care
- Ingestible electronic capsules and gut-targeted sensing
- Bioelectronic medicine and closed-loop neuromodulation
- Microfluidic lab-on-chip and droplet-based diagnostics
- FDA SaMD pathways and AI/ML medical device regulation